Flipboard Steve Jobs is a household name. To an extent, all three are true. However, there is more depth and complexity to his personality and character. From the onset of his career, Jobs became obsessed with the mission to create great products.
She is almost out of options for her hard-to-treat cancer, but she finds comfort in online support groups where other women with metastatic breast cancer share their experiences.
A new non-profit project from several leading health organizations that launched Thursday, called Count Me Inlets cancer patients send their medical information directly to researchers who are searching for cures. Count Me In allows cancer patients to send their medical information — including blood, saliva and tumor samples — to a public database that any researcher can access.
This information is invaluable to scientists who can use it to see patterns that might eventually lead to new understanding of how cancer works — and more importantly, to new drugs for treating it. So far, 5, people — including Doyle, who learned about the project on social media — have submitted their information, and the group hopes to includein the next few years.
The Broad, a leading genetics institute, performs the sequencing and for now will store the samples patients send in. People in the U. After signing up, they receive a kit by mail for providing a saliva sample; Count Me In contacts their hospitals to collect medical records and blood and tumor samples.
There are few effective treatments for pancreatic cancer, since most patients are diagnosed at late stages. The project is currently building four major databases — for metastatic breast cancer, metastatic prostate cancer, angiosarcoma and gastroesophageal cancer — and people like Doyle have been signing up after learning of the project through social media or advocates in the cancer community.
Count Me In plans to add other cancer databases in the future. Lander says Count Me In is an attempt to take advantage of an underappreciated resource: But combining that information from the hundreds of thousands of cancer patients who are treated by cancer doctors across the country — not just the ones who happen to live near academic centers — could teach doctors valuable lessons and provide new insights about novel ways to treat the disease.
This is a sea change in the idea of patients not just as subjects, but as partners. Why, for example, does some breast cancer spread beyond the breast tissue, and other breast cancer does not? Are there markers that researches can find to identify women who are most likely to develop metastatic disease?
Which treatments work best for which cancers, and why? The ability to contribute to finding such answers is what attracted Doyle to sign up. Barbara Bigelow, who was also diagnosed with metastatic breast cancer, is motivated by the same desire for answers.
The Massachusetts resident was diagnosed with stage 2 breast cancer in and had a lumpectomy, chemotherapy and radiation. Inshe learned her cancer had spread. Her two sisters were also diagnosed with the disease, so they all received genetic testing.
But none of them carry any of the genes known to contribute to breast cancer. Bigelow has two daughters who, because of their family history of breast cancer, have a high chance of developing the disease themselves.
But if researchers could find any genetic hint that they will get the disease, that could steer them toward early and more effective treatments — one of the goals of Count Me In. Because she lives near the Dana Farber Cancer Institute in Boston, in she joined a clinical trial that was testing the combination of a recently approved immune-based drug and chemotherapy.
The therapy took a toll — her immune system reacted so violently that she was hospitalized for two months and put into a medically induced coma as her kidneys started to shut down. After she recovered, however, her cancer had started to shrink, and two years later, she has no active signs of cancer.
Doctors are eager to study her genetics and her tumors to better understand why her cancer responded to the immunotherapy combination, and how more people like her with metastatic disease can benefit. Already, by scanning records provided from the few hundred people with angiosarcoma, a rare cancer, scientists have found a tantalizing hint for an effective new treatment.
Two of the people who have sent in their samples were treated by doctors with immunotherapy in a practice known as off-label use, in which physicians can use medications approved for one disease to treat another. For immunotherapy, having lots of mutations is a good thing: In less than a year, that finding has led to new studies that are enrolling people with angiosarcoma; these patients will test the immunotherapy to determine the best dose and timing of the treatment.
She found a French study showing some encouraging results with the chemotherapy drug Taxol, which is generally used to treat breast cancer.
After discussing it with her doctor, she began getting Taxol and has had no evidence of disease since Noce, Doyle, Bigelow and other people with cancer who are joining Count Me In are aware that they are donating their information not to find a treatment for themselves, but for future generations.
An app that Jobs and his team at Emerson developed will alert them when researchers are accessing the metastatic breast cancer or angiosarcoma database to which they contributed, but they may never know if their information led to a new treatment or insight that saves lives.
But I know that they have my information, and hopefully it will help researchers to come to some kind of resolution at some point.Essay steve jobs wozniak apple.
Is history important essay visual literacy life sample essay hooks english essay courses gandhiji economics essay natural resources. Example essay problem solution questions academic strengths essay goals sample essay band 7 blog writing a talk essay meaningful day essay fce sample interviews.
Death Steve Jobs died on October 5, from pancreatic cancer. He had fought cancer for several years since first being diagnosed in Interesting Facts about Steve Jobs.
Jobs got the name for Apple Computers after spending some time at an apple orchard. A Critique of the Leadership Style of Steve Jobs Kimberly Marie Celse Department of I-O Psychology Touro University Worldwide One of the most controversial yet wildly successful leaders of our time, Steve Jobs mesmerized the world with his passion for excellence yet infuriated many with his myopic drive.
Aug 23, · View CNN's Fast Facts to learn more about life of Steve Jobs, co-founder of Apple Inc., maker of the Macintosh computer, the iPod, the iPhone and the iPad. Usability and User Research for Websites, Software and Games.
Steve Jobs Even though there are still many Apple hold-outs, Steve Jobs has built up quite a reputation. Most respondents had positive things to say; 43% said he is innovative, % said he is a great businessman, and 32% said he is a genius.